Celmatix Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Celmatix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10416
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celmatix Inc (Celmatix) is a medicine company that develops infertility treatment products. The company provides products such as Polaris, an analytics platform for optimizing a woman’s fertility; and Fertilome test is a next generation sequencing panel that reveals genetic factors significantly associated with the reproductive conditions in women. It provides research services on reproductive functions in human by leveraging big data and genomics. Celmatix develops big-data analytics and genomics to optimize the treatment of infertility. The company has partnerships with various medical technology companies and universities in the US. Celmatix is headquartered in New York, the US.

Celmatix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celmatix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Celmatix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Celmatix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Celmatix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Celmatix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Celmatix Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Celmatix Raises USD4.8 Million in Venture Financing 10
Celmatix Raises USD3.8 Million in Financing Round 11
Celmatix Raises USD5.5 Million in Venture Financing 12
Celmatix Raises US$4 Million In Venture Financing 13
Celmatix Raises US$1.5 Million In Series B Financing 14
Partnerships 15
Celmatix Enters into Partnership with Oncotest-Teva 15
Celmatix Inc – Key Competitors 16
Celmatix Inc – Key Employees 17
Celmatix Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Feb 09, 2018: Celmatix Names Richard Hofbauer As COO and CFO 19
Dec 06, 2017: Celmatix Names Lori Batta as Chief Commercial Officer 20
Government and Public Interest 21
Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 21
Product News 22
Jan 11, 2017: Celmatix Announces Fertilome, the World’s First Comprehensive Screen for Genetic Factors Associated with Reproductive Conditions in Women 22
Other Significant Developments 23
Dec 18, 2017: Celmatix is Awarded $4.5M to Expand Footprint in New York City 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Celmatix Inc, Medical Equipment, Key Facts 2
Celmatix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Celmatix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Celmatix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Celmatix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Celmatix Inc, Deals By Market, 2012 to YTD 2018 8
Celmatix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Celmatix Raises USD4.8 Million in Venture Financing 10
Celmatix Raises USD3.8 Million in Financing Round 11
Celmatix Raises USD5.5 Million in Venture Financing 12
Celmatix Raises US$4 Million In Venture Financing 13
Celmatix Raises US$1.5 Million In Series B Financing 14
Celmatix Enters into Partnership with Oncotest-Teva 15
Celmatix Inc, Key Competitors 16
Celmatix Inc, Key Employees 17

List of Figures
Celmatix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Celmatix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Celmatix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Celmatix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Celmatix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Celmatix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Celmatix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Celmatix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Celmatix Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The People’s Insurance Company (Group) of China Limited:戦略・SWOT・企業財務分析
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Houghton Mifflin Harcourt Company:企業のM&A・事業提携・投資動向
    Houghton Mifflin Harcourt Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Houghton Mifflin Harcourt Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Keyera Corp (KEY):企業の財務・戦略的SWOT分析
    Keyera Corp (KEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MetaStat Inc (MTST):医療機器:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Sao Paulo Alpargatas S.A.:戦略・SWOT・企業財務分析
    Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report Summary Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務情報
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Omeros Corp (OMER):企業の財務・戦略的SWOT分析
    Omeros Corp (OMER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Henry Schein Inc (HSIC)-医療機器分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • Entasis Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Entasis Therapeutics Inc (Entasis) discovers and develops anti-infective products for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, a potent inhibitor of class A, C, and D beta-lactamases intended to treat serious gram-negative infections, such as Acin …
  • Summit Exploration and Production Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Exploration and Production Ltd (Summit), a subsidiary of Sumitomo Corp, is an independent upstream oil and gas company that explores, develops and produces oil and gas assets. The company holds operator interests for exploration in the UK North Sea. It has two production assets such a …
  • ANGLE Plc (AGL):医療機器:M&Aディール及び事業提携情報
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Tesla Motors, Inc.:企業の戦略・SWOT・財務情報
    Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Analytik Jena AG:医療機器:M&Aディール及び事業提携情報
    Summary Analytik Jena AG (Analytik Jena), a subsidiary of Endress+Hauser AG is a provider of instruments and products for analytical measuring technology and life science. The company’s major products include atomic spectrometers, optical emission spectroscopy devices, mass spectrometers, mercury an …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Protalex Inc (PRTX):企業の財務・戦略的SWOT分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Enterome Bioscience SA:企業の製品パイプライン分析2018
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆